Filter
1121
Text search:
adverse
reactions
Featured
146
289
Language
Document type
611
226
117
88
23
20
19
8
4
3
1
1
Countries
79
34
31
26
26
25
24
21
20
17
16
16
16
13
12
11
11
10
10
10
9
8
8
8
7
7
7
6
6
6
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
398
152
59
48
43
19
16
Toolboxes
125
110
80
72
65
37
30
26
25
24
23
19
17
16
14
12
10
9
8
6
6
6
5
1
Accessed November, 2017
Accessed November 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The document contains 2 decision trees, the first short one is to act fast and the second is to design better interventions
